SPOP and posterior cortical atrophy: Therefore, the impairment of DDR and the resulting high genomic instability due to SPOP gene mutations may contribute to the sensitivity of PCa to PARP inhibitors, which was partially supported by a clinical retrospective study (5) as well as by cellular and animal model studies, but not yet at the clinical level (9, 10, 29).